HealthTech

ApexAnalytics

ApexAnalytics Raises $200M Series D to Transform HealthTech

$200M Series D
Total Raised
Series
Latest Round
2023
Founded
250-500
Employees
Chicago, IL
1 min read

Quick Facts

Valuation
$4B
Latest Round Size
$200M Series D
Latest Round Date
October 2025

ApexAnalytics Raises $200M Series D in Latest Funding Round

ApexAnalytics has successfully closed a $200M Series D funding round, marking a significant milestone in the company's growth trajectory. The round was led by Lightspeed Venture Partners, with participation from Tiger Global.

Company Overview

Founded in 2023 and headquartered in Chicago, IL, ApexAnalytics has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI

With a current valuation of $4B, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $200M Series D
  • Valuation: $4B
  • Lead Investor: Lightspeed Venture Partners

Future Outlook

As ApexAnalytics moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

Lightspeed Venture Partners
Venture Capital
Leading venture capital firm investing in technology companies
Tiger Global
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Sarah Kim
Sarah Kim
Healthcare and biotech investment analyst with expertise in Series B+ rounds and strategic partnerships.